Huazue Testing (300012): Short-term performance is under pressure, and the layout of new fields accelerates long-term growth and can be expected
Southwest Securities released a research report on April 25 stating that it gave Huazue Testing (300012.SZ) a holding rating. The main reasons for the rating include: 1) steady development in traditional fields, industrial testing and consumer goods testi
Huazu Testing (300012): The pharmaceutical sector is under short-term pressure, and Sanpu's orders have entered the fulfillment period
Huatest Testing (300012): Revenue increased 6.7% year-on-year in the first quarter of 2024, and the pharmaceutical business is under pressure in the short term
Huatest Testing (300012): Medicine is under short-term pressure and is optimistic that leading testing companies will continue to grow steadily in the medium to long term
Huatest Testing (300012): Short-term pharmaceutical and medical testing companies under pressure have outstanding long-term competitiveness
Huazu Testing (300012): The pharmaceutical sector is under short-term pressure and long-term development is improving
Huatest Testing (300012): Short-term pressure on the pharmaceutical sector, marginal improvement in Q1 comprehensive gross margin
Guolian Securities released a research report on April 19 stating that the target price for HuaTest Testing (300012.SZ) was given a purchase rating of 27.58 yuan. The main reasons for the rating include: 1) all major sectors grew in 23, and medical testin
Huazue Testing (300012): Profit margins narrowed year-on-year due to structural factors
Huazue Testing (300012): 24Q1 revenue growth, external environment affects gross margin and decline under pressure
Huazue Testing (300012): Medicine drags down performance and performs well in multiple segments
Huazeng Testing (300012): Laying out a low-altitude economy, the leading inspection leader in the entire industry chain has an obvious first-mover advantage
Huazue Testing (300012): Released the “Double Improvement of Quality and Return” action plan, optimistic about increasing the investment value of leading testing companies
Huazuan Testing (300012): Private comprehensive testing leaders strategically lay out emerging fields to create a second growth curve
Huazue testing (300012): It is better to focus on trends, measure short-term pressure, and do not change long-term track attributes
Huazue Testing (300012): 23-year performance falls short of expectations, optimistic about the steady growth of leading testing companies in the medium to long term
Huazui Testing (300012): Diverse layout and forward-looking strategies achieve stable growth
Minsheng Securities: Maintaining the Machinery Industry's “Recommended” Rating, Focusing on the Recovery of General Manufacturing
Huazui Testing (300012): Performance Close to Forecast, Central Operations Remain Steady - Testing Service Series Report
No Data